Distinct morning and evening fatigue profiles in gastrointestinal cancer during chemotherapy.
depression
fatigue
gastrointestinal (lower)
pain
quality of life
Journal
BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123
Informations de publication
Date de publication:
07 Dec 2023
07 Dec 2023
Historique:
received:
19
01
2021
accepted:
08
05
2021
medline:
17
12
2023
pubmed:
30
5
2021
entrez:
29
5
2021
Statut:
epublish
Résumé
Purposes were to identify subgroups of patients with gastrointestinal cancers with distinct morning and evening fatigue severity profiles and evaluate for differences among these subgroups in demographic and clinical characteristics, co-occurring symptoms and quality of life (QOL) outcomes. Patients with gastrointestinal cancers (n=405) completed questionnaires six times over two cycles of chemotherapy. Latent profile analysis was used to identify distinct morning and evening fatigue profiles. Differences in demographic and clinical characteristics, co-occurring symptoms and QOL outcomes among the subgroups were evaluated using parametric and nonparametric tests. Two distinct mornings (ie, low and very high) and three distinct evenings (ie, low, moderate and very high) fatigue classes were identified. Common risk factors for both morning and evening fatigue included younger age, lower performance status, higher comorbidity burden and self-reported depression. Higher levels of morning fatigue were associated with being unmarried, living alone, being unemployed, having a lower income, lack of regular exercise and a self-reported diagnosis of anaemia. Higher levels of evening fatigue were associated with being women, white and having childcare responsibilities. Patients in the very high morning and evening fatigue classes reported higher levels of anxiety, depressive symptoms, sleep disturbance and pain and lower levels of attentional function and poorer QOL. Findings provide new insights into risk factors for and deleterious effects of morning and evening fatigue in patients with gastrointestinal cancers. Clinicians can use this information to identify high-risk patients and develop individualised interventions for morning and evening fatigue and other co-occurring symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Purposes were to identify subgroups of patients with gastrointestinal cancers with distinct morning and evening fatigue severity profiles and evaluate for differences among these subgroups in demographic and clinical characteristics, co-occurring symptoms and quality of life (QOL) outcomes.
METHODS
METHODS
Patients with gastrointestinal cancers (n=405) completed questionnaires six times over two cycles of chemotherapy. Latent profile analysis was used to identify distinct morning and evening fatigue profiles. Differences in demographic and clinical characteristics, co-occurring symptoms and QOL outcomes among the subgroups were evaluated using parametric and nonparametric tests.
RESULTS
RESULTS
Two distinct mornings (ie, low and very high) and three distinct evenings (ie, low, moderate and very high) fatigue classes were identified. Common risk factors for both morning and evening fatigue included younger age, lower performance status, higher comorbidity burden and self-reported depression. Higher levels of morning fatigue were associated with being unmarried, living alone, being unemployed, having a lower income, lack of regular exercise and a self-reported diagnosis of anaemia. Higher levels of evening fatigue were associated with being women, white and having childcare responsibilities. Patients in the very high morning and evening fatigue classes reported higher levels of anxiety, depressive symptoms, sleep disturbance and pain and lower levels of attentional function and poorer QOL.
CONCLUSION
CONCLUSIONS
Findings provide new insights into risk factors for and deleterious effects of morning and evening fatigue in patients with gastrointestinal cancers. Clinicians can use this information to identify high-risk patients and develop individualised interventions for morning and evening fatigue and other co-occurring symptoms.
Identifiants
pubmed: 34049967
pii: bmjspcare-2021-002914
doi: 10.1136/bmjspcare-2021-002914
pmc: PMC8627530
mid: NIHMS1721104
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e373-e381Subventions
Organisme : NCI NIH HHS
ID : R01 CA134900
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
J Gastrointest Oncol. 2017 Feb;8(1):109-126
pubmed: 28280616
Support Care Cancer. 2019 Aug;27(8):3007-3017
pubmed: 30607676
Biol Res Nurs. 2015 Mar;17(2):175-84
pubmed: 24872120
Psychooncology. 2011 Feb;20(2):194-202
pubmed: 20213858
Qual Life Res. 2018 Jul;27(7):1865-1876
pubmed: 29679368
J Pain Symptom Manage. 2015 Aug;50(2):176-89
pubmed: 25828559
J Clin Nurs. 2011 Aug;20(15-16):2204-16
pubmed: 21752119
Rev Lat Am Enfermagem. 2012 May-Jun;20(3):495-503
pubmed: 22991111
J Pain Symptom Manage. 2016 Oct;52(4):539-547
pubmed: 27470003
J Pain Symptom Manage. 2018 Mar;55(3):808-834
pubmed: 29051114
J Geriatr Oncol. 2014 Oct 1;5(4):359-67
pubmed: 24981125
Oncol Nurs Forum. 2010 Nov;37(6):E359-69
pubmed: 21059569
Sleep. 1992 Dec;15(6):493-8
pubmed: 1475563
Fatigue. 2017;5(3):131-144
pubmed: 29725554
Psychiatry Res. 1991 Mar;36(3):291-8
pubmed: 2062970
Breast Cancer Res Treat. 2020 Nov;184(1):1-9
pubmed: 32803635
Cancer Nurs. 1990 Apr;13(2):108-15
pubmed: 2331691
Struct Equ Modeling. 2014;21(2):263-279
pubmed: 24729675
Eur J Oncol Nurs. 2013 Dec;17(6):841-8
pubmed: 24012189
J Pain Symptom Manage. 2017 May;53(5):887-900.e2
pubmed: 28063861
Eur J Oncol Nurs. 2004 Dec;8(4):334-40
pubmed: 15550363
Ann Oncol. 1999 Jul;10(7):747-9
pubmed: 10470418
Scand J Caring Sci. 1998;12(1):3-10
pubmed: 9601440
Cytokine. 2017 Mar;91:187-210
pubmed: 28110208
Pain. 1983 Oct;17(2):197-210
pubmed: 6646795
Front Immunol. 2020 Feb 21;11:249
pubmed: 32153576
Cancer. 2019 Feb 1;125(3):353-364
pubmed: 30602059
Curr Treat Options Oncol. 2020 Feb 5;21(2):17
pubmed: 32025928
Eur J Oncol Nurs. 2020 Dec;49:101860
pubmed: 33126154
Oncol Nurs Forum. 2020 Mar 1;47(2):187-202
pubmed: 32078617
Cancer Nurs. 2019 Sep/Oct;42(5):355-364
pubmed: 30024437
J Clin Oncol. 2008 Feb 1;26(4):599-605
pubmed: 18235118
Psychosomatics. 2007 May-Jun;48(3):247-52
pubmed: 17478594
Ann Oncol. 2016 Sep;27(9):1761-7
pubmed: 27443634
Support Care Cancer. 2014 May;22(5):1171-9
pubmed: 24337684
Cancer Nurs. 2016 Nov-Dec;39(6):437-445
pubmed: 26895413
Cancer. 2020 Aug 1;126(15):3526-3533
pubmed: 32436610
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Support Care Cancer. 2016 Apr;24(4):1473-85
pubmed: 26361758